Aurobindo Pharma arm CuraTeQ gets Health Canada NOC for Bevacizumab biosimilar

The Hindu online

www.thehindu.com

Aurobindo Pharma subsidiary CuraTeQ Biologics has received Notice of Compliance (NOC) from Health Canada’s Biologics and Radiopharmaceutical Drugs Directorate (BRDD) for Bevqolva, its bevacizumab biosimilar.A humanised monoclonal antibody, Bevacizumab slows tumor vascular growth and treats multipl